These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18313596)

  • 21. Defibrillation threshold testing in implantable cardioverter-defibrillators: might less be more than enough?
    Curtis AB
    J Am Coll Cardiol; 2008 Aug; 52(7):557-8. PubMed ID: 18687250
    [No Abstract]   [Full Text] [Related]  

  • 22. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system].
    Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G
    Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical value of routine predischarge testing after ICD-implantation.
    Buob A; Siaplaouras S; Tscholl D; Schäfers HJ; Böhm M; Jung J
    Europace; 2004 Mar; 6(2):159-64. PubMed ID: 15018876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can incremental innovation of implantable cardioverter-defibrillator systems become disruptive to patient care? Moore's law gone awry.
    Naccarelli GV
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):621-2. PubMed ID: 16836710
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical impact, safety, and efficacy of single- versus dual-coil ICD leads in MADIT-CRT.
    Kutyifa V; Huth Ruwald AC; Aktas MK; Jons C; McNitt S; Polonsky B; Geller L; Merkely B; Moss AJ; Zareba W; Bloch Thomsen PE
    J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1246-52. PubMed ID: 23889863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W
    Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems.
    Day JD; Olshansky B; Moore S; Brown S; Stolen KQ; Lerew DR;
    Europace; 2008 Mar; 10(3):347-50. PubMed ID: 18308755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-hospital discharge testing after implantable cardioverter defibrillator implantation: a measure of safety or out of date? A retrospective analysis of 975 patients.
    Guenther M; Rauwolf T; Brüggemann B; Gerlach M; Wässnig NK; Christoph M; Braun MU; Strasser RH; Wunderlich C
    Europace; 2012 Feb; 14(2):217-23. PubMed ID: 21969525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High defibrillation threshold in patients with implantable defibrillator: how effective is the subcutaneous finger lead?
    Osswald BR; De Simone R; Most S; Tochtermann U; Tanzeem A; Karck M
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):489-92. PubMed ID: 19144533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up.
    Bianchi S; Ricci RP; Biscione F; Sgreccia F; Di Belardino N; Rossi P; Giuli S; Grammatico A; De Santo T; Santi E; Merico M; Piccirillo G; Azzolini P; Santini M; Puglisi A
    Pacing Clin Electrophysiol; 2009 May; 32(5):573-8. PubMed ID: 19422577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Safety and efficacy of intraoperative defibrillation threshold measured by defibrillation safety margin in 52 patients with implantable cardioverter defibrillator].
    Zhang Y; Yuan KD; Tang BP; Ma YT; Zhang YY; Wang J; Li JX; Zhang JH; Xu GJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Nov; 38(11):975-8. PubMed ID: 21215224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced ICD troubleshooting: Part I.
    Swerdlow CD; Friedman PA
    Pacing Clin Electrophysiol; 2005 Dec; 28(12):1322-46. PubMed ID: 16403166
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of defibrillation testing on predicted ICD shock efficacy: implications for clinical practice.
    Smits K; Virag N; Swerdlow CD
    Heart Rhythm; 2013 May; 10(5):709-17. PubMed ID: 23369742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defibrillation testing can reveal 'concealed' lead fracture.
    Bun SS; Duytschaever M; Tavernier R
    Europace; 2013 Jan; 15(1):54. PubMed ID: 22719061
    [No Abstract]   [Full Text] [Related]  

  • 35. Defibrillation threshold testing and neurologic outcome.
    Karaoğuz R
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():47-9. PubMed ID: 17584679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Relationship Between Cardiac Vulnerability and Restitution Properties of the Ventricular Activation Recovery Interval.
    Yamashita S; Yoshida A; Fukuzawa K; Nakanishi T; Matsumoto A; Konishi H; Ichibori H; Hyogo K; Imada H; Hirata K
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):768-73. PubMed ID: 25810143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced ICD troubleshooting: Part II.
    Swerdlow CD; Friedman PA
    Pacing Clin Electrophysiol; 2006 Jan; 29(1):70-96. PubMed ID: 16441722
    [No Abstract]   [Full Text] [Related]  

  • 38. Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial.
    Bänsch D; Bonnemeier H; Brandt J; Bode F; Svendsen JH; Táborský M; Kuster S; Blomström-Lundqvist C; Felk A; Hauser T; Suling A; Wegscheider K;
    Eur Heart J; 2015 Oct; 36(37):2500-7. PubMed ID: 26112885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Azygous vein coil lowers defibrillation threshold in patients with high defibrillation threshold.
    Seow SC; Tolentino CS; Zhao J; Lim TW
    Europace; 2011 Jun; 13(6):825-8. PubMed ID: 21436136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers to patients eligible for screening investigations and insertion of primary prevention implantable cardioverter defibrillators.
    Sadarmin PP; Wong KC; Rajappan K; Bashir Y; Betts TR
    Europace; 2014 Nov; 16(11):1575-9. PubMed ID: 24668515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.